# Efficacy and Safety of Oxymorphone Immediate Release in Post-surgical Acute Pain

> **NCT00226395** · PHASE3 · COMPLETED · sponsor: **Endo Pharmaceuticals** · enrollment: 320 (—)

## Conditions studied

- Acute Pain

## Interventions

- **DRUG:** Oxymorphone immediate release

## Key facts

- **NCT ID:** NCT00226395
- **Lead sponsor:** Endo Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-09
- **Primary completion:** —
- **Final completion:** 2005-08
- **Target enrollment:** 320 (—)
- **Last updated:** 2024-01-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00226395

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00226395, "Efficacy and Safety of Oxymorphone Immediate Release in Post-surgical Acute Pain". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00226395. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*